NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Size: px
Start display at page:

Download "NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE"

Transcription

1 DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary care (partial update) 1.1 Short title COPD (partial update) 2 Background a) The National Institute for Health and Clinical Excellence ( NICE or the Institute ) has commissioned the National Collaborating Centre for Chronic Conditions to review recent evidence on chronic obstructive pulmonary disease and to update some sections of the existing guideline Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care (NICE clinical guideline 12, 2004) for use in the NHS in England and Wales. The guideline will provide recommendations for good practice that are based on the best available evidence of clinical and cost effectiveness. b) NICE clinical guidelines support the implementation of National Service Frameworks (NSFs) in those aspects of care where a Framework has been published. The statements in each NSF reflect the evidence that was used at the time the Framework was prepared. The clinical guidelines and technology appraisals published by NICE after an NSF has been issued have the effect of updating the Framework. COPD partial update draft scope for consultation (22 Sept 20 Oct 2008) Page 1 of 14

2 DRAFT c) NICE clinical guidelines support the role of healthcare professionals in providing care in partnership with patients, taking account of their individual needs and preferences, and ensuring that patients (and their carers and families, if appropriate) can make informed decisions about their care and treatment. 3 Clinical need for the guideline a) Since the publication of NICE clinical guideline 12 (2004), there has been progress in the management of chronic obstructive pulmonary disease (COPD) and the importance of systemic aspects of the disease also has been recognised. New initiatives such as the introduction of the Quality and Outcomes Framework for General Practice have helped the delivery of evidence-based care. But COPD is still a common cause of morbidity and mortality in England and Wales. b) People with COPD experience progressive breathlessness and reduction in exercise capacity. Exacerbations frequently result in hospital admission. COPD remains the fifth most common cause of death in England and Wales, accounting for more than 26,000 deaths in It is also one of the ten most common causes of hospital admission. Many patients, including those with severe airflow obstruction, remain undiagnosed even though diagnostic testing using spirometry is increasingly available. c) The development of a National Service Framework for COPD was announced in 2006 and it is expected that this will be published in late 2008 or early A partial update of the guideline is necessary to ensure consistency between recommendations in the guideline and the NSF, and to take the new evidence into account. 4 The guideline a) The guideline development process is described in detail in two publications that are available from the NICE website (see Further COPD partial update draft scope for consultation (22 Sept 20 Oct 2008) Page 2 of 14

3 DRAFT information ). The guideline development process: an overview for stakeholders, the public and the NHS describes how organisations can become involved in the development of a guideline. The guidelines manual provides advice on the technical aspects of guideline development. b) This scope defines what this guideline will (and will not) examine, and what the guideline developers will consider. This scope should be read along with the original scope for Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care (NICE clinical guideline 12, 2004), which is reproduced in the appendix. c) The areas that will be addressed by the guideline are described in the following sections. 4.1 Population Groups that will be covered a) Adults with stable COPD (including chronic bronchitis, emphysema and chronic airflow limitation/obstruction) Groups that will not be covered a) People with asthma, bronchopulmonary dysplasia or bronchiectasis. b) Children younger than 16 years. c) People with exacerbations of COPD. 4.2 Healthcare setting a) Care given by primary and secondary healthcare professionals who have responsibility for patients with COPD and who make decisions concerning their care. COPD partial update draft scope for consultation (22 Sept 20 Oct 2008) Page 3 of 14

4 DRAFT b) The guideline will also be relevant to the work, but will not cover the practice, of social services or patient support groups. 4.3 Clinical management a) Diagnosis and severity classification, including: spirometry and post bronchodilator values multidimensional severity assessment indices, for example, BODE index. b) Management of stable COPD and prevention of progression (updates section 7 of NICE clinical guideline 12) to include: long-acting bronchodilators: beta 2 -agonists and anticholinergics (monotherapy and in combination with inhaled corticosteroids) mucolytic therapy. c) Note that guideline recommendations will normally fall within licensed indications; exceptionally, and only if clearly supported by evidence, use outside a licensed indication may be recommended. The guideline will assume that prescribers will use a drug s summary of product characteristics to inform their decisions for individual patients. d) The Guideline Development Group will take reasonable steps to identify ineffective interventions and approaches to care. If robust and credible recommendations for re-positioning the intervention for optimal use, or changing the approach to care to make more efficient use of resources, can be made, they will be clearly stated. If the resources released are substantial, consideration will be given to listing such recommendations in the Key priorities for implementation section of the guideline. COPD partial update draft scope for consultation (22 Sept 20 Oct 2008) Page 4 of 14

5 DRAFT 4.4 Status Scope This is the consultation draft of the scope. The consultation period is 22 September to 20 October. The guideline will update the following NICE guidance. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. NICE clinical guideline 12 (2004). The guideline will incorporate the following NICE guidance. Varenicline for smoking cessation. NICE technology appraisal guidance 123 (2007) Guideline The development of the guideline recommendations will begin in September Further information The guideline development process is described in: The guideline development process: an overview for stakeholders, the public and the NHS The guidelines manual. These are available from the NICE website ( Information on the progress of the guideline will also be available from the website. COPD partial update draft scope for consultation (22 Sept 20 Oct 2008) Page 5 of 14

6 Appendix: Scope for NICE clinical guideline 12 NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary care 1.1 Short title COPD 2 Background a) The National Institute for Clinical Excellence ( NICE or the Institute ) has commissioned the National Collaborating Centre for Chronic Conditions to develop a clinical guideline on the management of chronic obstructive pulmonary disease for use in the NHS in England and Wales. This follows referral of the topic by the Department of Health and National Assembly for Wales (see appendix). The guideline will provide recommendations for good practice that are based on the best available evidence of clinical and cost effectiveness. b) The Institute s clinical guidelines will support the implementation of National Service Frameworks (NSFs) in those aspects of care where a Framework has been published. The statements in each NSF reflect the evidence that was used at the time the Framework was prepared. The clinical guidelines and technology appraisals published by the Institute after an NSF has been issued will have the effect of updating the Framework. Scope for NICE clinical guideline 12 (2004) Page 6 of 14

7 3 Clinical need for the guideline a) COPD is the fifth commonest cause of death in England and Wales, accounting for nearly 28,000 deaths each year and Britain has one of the highest death rates from COPD in the European Union. It is estimated that there are about 600,000 patients in the UK with diagnosed COPD and there may be as many again who remain undiagnosed. COPD patients are frequent users of primary and secondary care services with an estimate of one in eight hospital admissions being due to COPD. Consultation rates in general practice rise with age from 417 in those aged per 10,000 population per year to 1032 in those aged per year per 10,000 population (BTS, 1997). COPD results in an estimated 27 million lost working days per year. b) Recent national guidelines in the area include the guideline developed by the British Thoracic Society (Thorax 1997; 52 [suppl 5]; S1), the GOLD International guidelines (2001), Use of Nebulisers (Thorax 1997; 52 [suppl 2]) and the NIV guidelines (in press: Thorax). c) Technology appraisals on the Institute s programme that will inform this guideline include guidance on zanamivir (Relenza) for influenza, smoking cessation treatments and nicotine replacement therapy (expected March 2002) and comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature (Health Technology Assessment 2001; Vol. 5: No. 26). 4 The guideline a) The guideline development process is described in detail in three booklets that are available from the NICE website (see Further information ). The Guideline Development Process Information for Stakeholders describes how organisations can become involved in the development of a guideline. Scope for NICE clinical guideline 12 (2004) Page 7 of 14

8 b) This document is the scope. It defines exactly what this guideline will (and will not) examine, and what the guideline developers will consider. The scope is based on the referral from the Department of Health and National Assembly for Wales (see Box). c) The areas that will be addressed by the guideline are described in the following sections. 4.1 Population Groups that will be covered a) The guideline will offer best practice advice on the care of adults who have a clinical working diagnosis of COPD including chronic bronchitis, emphysema, and chronic airflow limitation/obstruction Groups that will not be covered a) The guideline will not cover the management of people with asthma, bronchopulmonary dysplasia or bronchiectasis. b) The guideline will not cover children (aged < 16 years). 4.2 Healthcare setting a) The guideline will cover the care received from primary and secondary healthcare professionals who have direct contact with and make decisions concerning the care of patients with COPD. b) The guideline will also be relevant to the work, but will not cover the practice, of social services, patient support groups or palliative care services. 4.3 Clinical management The guideline will include recommendations in the following areas. a) Diagnostic criteria, including the role of spirometry in primary and secondary care. Scope for NICE clinical guideline 12 (2004) Page 8 of 14

9 b) Identification of early disease to facilitate preventative approaches. The guideline will not cover general population screening, but will include opportunistic case find. c) Management of stable patients, management of acute exacerbations and prevention of progression of the disease, to include: smoking cessation, including pharmacological and nonpharmacological approaches as they relate specifically to COPD bronchodilator management including methods of delivery and methods of assessing efficacy inhaled and oral corticosteroid therapy non-pharmacological interventions, including pulmonary rehabilitation and respiratory physiotherapy, lifestyle advice including nutritional/metabolic assessment and management and self-management techniques the management of right heart failure as it pertains to COPD oxygen therapy including when It should be used and what type is appropriate in different circumstances non-invasive ventilation indications for surgery d) Criteria for admission and/or management at home of exacerbations. e) Management of depression and/or anxiety as it pertains directly to patients with COPD and is outside the scope of the Management of Depression guideline which is under development. f) Advice on treatment options will be based on the best evidence available to the development group. When referring to pharmacological treatments, the guideline will normally recommend use within licensed indications. Exceptionally, and only where the evidence clearly supports it, recommendations for the guideline Scope for NICE clinical guideline 12 (2004) Page 9 of 14

10 may recommend use outside the licence indications. The guideline assumes that prescribers will use the Summary of Product Characteristics to inform their prescribing decisions for individual patients. 4.4 Audit support within guideline The guideline will include review criteria for audit. 4.5 Status Scope This is the final version of the scope Guideline The development of the guideline recommendations will begin in the second quarter of Further information Information on the guideline development process is provided in: The Guideline Development Process Information for the Public and the NHS The Guideline Development Process Information for Stakeholders The Guideline Development Process Information for National Collaborating Centres and Guideline Development Groups. These booklets are available as PDF files from the NICE website ( Information of the progress of the guideline will also be available from the website. 6 References BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997; 52 Suppl 5:S1-28. Scope for NICE clinical guideline 12 (2004) Page 10 of 14

11 Current best practice for nebuliser treatment. British Thoracic Society Nebulizer Project Group [published erratum appears in Thorax 1997 Sep; 52(9): 838] Thorax 1997; 52 (Suppl 2): S1-S3. Pocket Guide to COPD Diagnosis, Management, and Prevention. Global Initiative for Chronic Obstructive Lung Disease; U.S. Department of Health and Human Services; Public Health Service; National Institutes of Health; National Heart, Lung, and Blood Institute; NIH Publication No. 2701B Referral from the Department of Health and National Assembly for Wales To prepare clinical guidelines for the NHS in England and Wales for the prevention, diagnosis, management and treatment of COPD. Scope for NICE clinical guideline 12 (2004) Page 11 of 14

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary

More information

National Institute for Health and Clinical Excellence SCOPE. Rheumatoid arthritis: the management and treatment of rheumatoid arthritis in adults

National Institute for Health and Clinical Excellence SCOPE. Rheumatoid arthritis: the management and treatment of rheumatoid arthritis in adults National Institute for Health and Clinical Excellence 1 Guideline title SCOPE Rheumatoid arthritis: the management and treatment of rheumatoid arthritis in adults 1.1 Short title Rheumatoid arthritis 2

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE The management of faecal incontinence in adults 1.1 Short title Faecal incontinence 2 Background (a) (b) (c) The National Institute

More information

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease 0 Chronic obstructive pulmonary disease Implementing NICE guidance June 2010 NICE clinical guideline 101 What this presentation covers Background Scope Key priorities for implementation Discussion Find

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic fatigue syndrome/myalgic encephalomyelitis: diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis in

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension 1.1 Short title Glaucoma 2 Background

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update)

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Type 2 diabetes: the management of type 2 diabetes (update) NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Type 2 diabetes: the management of type 2 diabetes (update) 1.1 Short title Type 2 diabetes (update) 2 Background a) The National

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic kidney disease: early identification and management of adults with chronic kidney disease in primary and secondary

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Clinical guideline for the management of atrial fibrillation

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Clinical guideline for the management of atrial fibrillation NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Clinical guideline for the management of atrial fibrillation 1.1 Short title Atrial fibrillation 2 Background a) The National Institute

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Scope for Partial Update 1 Guideline title Anxiety: management of generalised anxiety disorder in adults in primary, secondary and community care (update)

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary tract infection: diagnosis, treatment and long-term management of urinary tract infection in children 1.1 Short title

More information

educating people and transforming lives worldwide

educating people and transforming lives worldwide Takingaction, educating people and transforming lives worldwide COPD elearning Diploma (Level 5) Module 2012 CONTENTS PAGE UNIT 1: WRITING FOR SUCCESS Writing for Success 2 UNIT 2: INTRODUCTION TO COPD

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Dementia: the management of dementia, including the use of antipsychotic medication in older people 1.1 Short title Dementia 2 Background

More information

Commissioning for Better Outcomes in COPD

Commissioning for Better Outcomes in COPD Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Constipation: the diagnosis and management of idiopathic childhood constipation in primary and secondary care 1.1 Short title

More information

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE 1 Guideline title SCOPE Bronchiolitis: diagnosis and management of bronchiolitis in children. 1.1 Short title Bronchiolitis in children 2 The remit The

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE. Personality Disorder: the clinical management of borderline personality disorder NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Personality Disorder: the clinical management of borderline personality disorder 1.1 Short title Borderline personality disorder

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Drug Misuse: opiate detoxification of drug misusers in the community, hospital and prison. 1.1 Short title Drug misuse detoxification

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Urinary incontinence: the management of urinary incontinence in women

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Urinary incontinence: the management of urinary incontinence in women NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Urinary incontinence: the management of urinary incontinence in women 1.1 Short title Urinary incontinence 2 Background a) The National

More information

Chronic Obstructive Pulmonary Disease (COPD) Measures Document

Chronic Obstructive Pulmonary Disease (COPD) Measures Document Chronic Obstructive Pulmonary Disease (COPD) Measures Document COPD Version: 3 - covering patients discharged between 01/10/2017 and present. Programme Lead: Jo Higgins Clinical Lead: Dr Paul Albert Number

More information

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding.

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Nutrition support in adults: oral supplements, enteral and parenteral feeding. NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Nutrition support in adults: oral supplements, enteral and parenteral feeding. 1.1 Short title Nutrition support 2 Background a) The National

More information

Hull and East Riding. Chronic Obstructive Pulmonary. Disease (COPD) Equity Audit

Hull and East Riding. Chronic Obstructive Pulmonary. Disease (COPD) Equity Audit Hull and East Riding Chronic Obstructive Pulmonary Disease (COPD) Equity Audit December 2010 Robert Sheikh Iddenden, Andrew Taylor, Jenny Walker Hull and East Riding Chronic Obstructive Pulmonary Disease

More information

Surveillance report Published: 6 April 2016 nice.org.uk. NICE All rights reserved.

Surveillance report Published: 6 April 2016 nice.org.uk. NICE All rights reserved. Surveillance report 2016 Chronic obstructive pulmonary disease in over 16s: diagnosis and management (2010) NICE guideline CG101 Surveillance report Published: 6 April 2016 nice.org.uk NICE 2016. All rights

More information

CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHRONIC OBSTRUCTIVE PULMONARY DISEASE A F O C A l p O I N T l E A r N I N g p r O g r A m m E CHRONIC OBSTRUCTIVE PULMONARY DISEASE S E C O N D E D I T I O N BOOK 1 September 2013 FP120/1 CENTRE FOR PHARMACY POSTGRADUATE EDUCATION About CPPE

More information

Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center

Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center Optimum COPD Care in 2010 Why Not Now? David E. Taylor, M.D. Pulmonary/Critical Care Ochnser Medical Center dtaylor@ochsner.org Observations from Yesterday EPIC is epidemic No EMR No Way!!! Accountability/Benchmarking

More information

Roflumilast (Daxas) for chronic obstructive pulmonary disease

Roflumilast (Daxas) for chronic obstructive pulmonary disease Roflumilast (Daxas) for chronic obstructive pulmonary disease August 2009 This technology summary is based on information available at the time of research and a limited literature search. It is not intended

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

An Outcomes Strategy for COPD and Asthma: NHS Companion Document IMPACT REPORT

An Outcomes Strategy for COPD and Asthma: NHS Companion Document IMPACT REPORT An Outcomes Strategy for COPD and Asthma: NHS Companion Document IMPACT REPORT 1 DH INFORMATION READER BOX Policy Clinical Estates HR / Workforce Commissioner Development IM & T Management Provider Development

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Myocardial infarction: secondary prevention in primary and secondary care for patients following a myocardial infarction 1.1

More information

Guideline scope Smoking cessation interventions and services

Guideline scope Smoking cessation interventions and services 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 Topic NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Smoking cessation interventions and services This guideline

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Motor neurone disease: the use of non-invasive ventilation in the management of motor neurone disease 1.1 Short title Motor

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Psychosis and schizophrenia in children and young people: recognition and management 1.1 Short title Psychosis and schizophrenia

More information

CARE OF THE ADULT COPD PATIENT

CARE OF THE ADULT COPD PATIENT CARE OF THE ADULT COPD PATIENT Target Audience: The target audience for this clinical guideline is all MultiCare providers and staff including those associated with our Clinically Integrated Network. The

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Constipation: management of idiopathic constipation in children in primary and secondary care 1.1 Short title Constipation

More information

Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Chronic obstructive pulmonary disease in over 16s: diagnosis and management National Institute for Health and Care Excellence Draft for consultation Chronic obstructive pulmonary disease in over 16s: diagnosis and management [D] Diagnosing COPD and predicting outcomes NICE guideline

More information

Chronic Obstructive Pulmonary Disease (COPD).

Chronic Obstructive Pulmonary Disease (COPD). Chronic Obstructive Pulmonary Disease (COPD). Linde: Living healthcare 02 03 Chronic Obstructive Pulmonary Disease (COPD). A pocket guide for healthcare professionals. COPD the facts Moderate to severe

More information

Yorkshire & Humber Respiratory Programme Report

Yorkshire & Humber Respiratory Programme Report 2013 NHS Bassetlaw Clinical Commissioning Group Yorkshire & Humber Respiratory Programme Report This report has been produced by the Yorkshire & Humber Respiratory Team. It highlights opportunities that

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Management of meningitis and meningococcal disease in children and young people in primary and secondary care. 1.1 Short title

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Personality disorder: the management and prevention of antisocial (dissocial) personality disorder 1.1 Short title Antisocial

More information

Policy position statement Chronic Obstructive Pulmonary Disease (COPD) May 2017 Introduction

Policy position statement Chronic Obstructive Pulmonary Disease (COPD) May 2017 Introduction Policy position statement Chronic Obstructive Pulmonary Disease (COPD) May 2017 Introduction The British Lung Foundation recommends: Improvements to COPD diagnosis speed and accuracy through better symptom

More information

Pathway diagrams Annex F

Pathway diagrams Annex F Pathway diagrams Annex F Fig 1 Asthma: The patient journey Asthma is diagnosed Making the diagnosis of asthma Confirming the diagnosis may depend on history, response to treatment, measurement of airflow

More information

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease National Institute for Clinical Excellence Issue date: February 2004 Quick reference guide Chronic obstructive pulmonary disease Management of chronic obstructive pulmonary disease in adults in primary

More information

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease Chronic obstructive pulmonary disease Management of chronic obstructive pulmonary disease in adults in primary and secondary care Clinical Guideline 12 February 2004 eveloped by the National Collaborating

More information

COPD GOLD Guidelines & Barnet inhaler choices. Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust

COPD GOLD Guidelines & Barnet inhaler choices. Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust COPD GOLD Guidelines & Barnet inhaler choices Dr Dean Creer, Respiratory Consultant, Royal Free London NHS Foundation Trust GOLD 2017 Report: Chapters 1. Definition and Overview 2. Diagnosis and Initial

More information

COPD: Current Medical Therapy

COPD: Current Medical Therapy COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for

More information

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see: bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest

More information

COPD/ Asthma. Dr Heather Lewis Honorary Clinical Lecturer

COPD/ Asthma. Dr Heather Lewis Honorary Clinical Lecturer COPD/ Asthma Dr Heather Lewis Honorary Clinical Lecturer Objectives To understand the pathogenesis of asthma/ COPD To recognise the clinical features of asthma/ COPD To know how to diagnose asthma/ COPD

More information

Yorkshire & Humber Respiratory Programme Report

Yorkshire & Humber Respiratory Programme Report 2013 NHS Doncaster Clinical Commissioning Group Yorkshire & Humber Respiratory Programme Report This report has been produced by the Yorkshire & Humber Respiratory Team. It highlights opportunities that

More information

Yorkshire & Humber Respiratory Programme Report. NHS Hambleton, Richmondshire and Whitby Clinical Commissioning Group

Yorkshire & Humber Respiratory Programme Report. NHS Hambleton, Richmondshire and Whitby Clinical Commissioning Group 2013 NHS Hambleton, Richmondshire and Whitby Clinical Commissioning Group Yorkshire & Humber Respiratory Programme Report This report has been produced by the Yorkshire & Humber Respiratory Team. It highlights

More information

National COPD Audit Programme

National COPD Audit Programme National COPD Audit Programme Planning for every breath National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Primary care audit () 2015 17 Data analysis and methodology Section 4: Providing

More information

Confidence and understanding among general practitioners and practice nurses in the UK about diagnosis and management of COPD

Confidence and understanding among general practitioners and practice nurses in the UK about diagnosis and management of COPD Respiratory Medicine (2007) 101, 2378 2385 Confidence and understanding among general practitioners and practice nurses in the UK about diagnosis and management of COPD D.M.G. Halpin a,, J.F. O Reilly

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Psychosis and schizophrenia in adults: treatment and management Quality standard title:

More information

Does this information apply to me? Information for the public Published: 1 June 2010 nice.org.uk

Does this information apply to me? Information for the public Published: 1 June 2010 nice.org.uk Information for the public Published: 1 June 2010 nice.org.uk About this information NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and the treatments

More information

OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures

OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING 10/16/2018 DISCLOSURES I have no financial or other disclosures OPTIMIZING MANAGEMENT OF COPD IN THE PRACTICE SETTING J. Michael Fuller, MD, MEd, FACP, FCCP Associate Professor of Medicine University of South Carolina Greenville DISCLOSURES I have no financial or other

More information

National COPD Audit Programme

National COPD Audit Programme National COPD Audit Programme Planning for every breath Primary Care Audit (Wales) 2015-17 Findings and quality improvement The audit programme partnership Working in strategic partnership: Supported by:

More information

CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease

CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease CLINICAL PATHWAY Acute Medicine Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease Table of Contents (tap to jump to page) INTRODUCTION 1 Scope of this Pathway 1 Pathway Contacts

More information

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease Chronic obstructive pulmonary disease Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update) Issued: June 2010 NICE clinical guideline 101 guidance.nice.org.uk/cg101

More information

Bronchodilator Delivery and Nebuliser Trials in Adults

Bronchodilator Delivery and Nebuliser Trials in Adults Bronchodilator Delivery and Nebuliser Trials in Adults Acute Management Favour the use of MDI (+/- Spacer) If considering nebuliser Short term treatment Approx. < 3 weeks See optimisation of inhaled bronchodilators

More information

Care Bundle. Adult patients with COPD

Care Bundle. Adult patients with COPD Care Bundle Adult patients with COPD Version 2 July 2014 What is a care bundle? A care bundle is a set of interventions that, when used together, significantly improve patient outcomes. The measures chosen

More information

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease 07 Contributor Dr David Tan Hsien Yung Definition, Diagnosis and Risk Factors for (COPD) Differential Diagnoses Goals of Management Management of COPD THERAPY AT EACH

More information

Yorkshire & Humber Respiratory Programme Report

Yorkshire & Humber Respiratory Programme Report 2013 NHS Harrogate & Rural District Clinical Commissioning Group Yorkshire & Humber Respiratory Programme Report This report has been produced by the Yorkshire & Humber Respiratory Team. It highlights

More information

Defining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist

Defining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease

More information

What s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM

What s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM What s New in Acute COPD? Dr Nick Scriven Consultant AIM President SAM Covering: Basic Definition New assessment criteria Some newer treatments BiPAP Not Covering: Definitions: Chronic Obstructive Pulmonary

More information

Chronic obstructive pulmonary disease

Chronic obstructive pulmonary disease nice bulletin Chronic obstructive pulmonary disease NICE provided the content for this booklet which is independent of any company or product advertised nice bulletin Chronic obstructive pulmonary disease

More information

RESPIRATORY CARE IN GENERAL PRACTICE

RESPIRATORY CARE IN GENERAL PRACTICE RESPIRATORY CARE IN GENERAL PRACTICE Definitions of Asthma and COPD Asthma is due to inflammation of the air passages in the lungs and affects the sensitivity of the nerve endings in the airways so they

More information

Managing COPD. Richard EK Russell Imperial College London, UK. Paul A Ford Imperial College London, UK

Managing COPD. Richard EK Russell Imperial College London, UK. Paul A Ford Imperial College London, UK Managing COPD Managing COPD Richard EK Russell Imperial College London, UK Paul A Ford Imperial College London, UK Peter J Barnes National Heart and Lung Institute, Imperial College London, London, UK

More information

Treatment. Assessing the outcome of interventions Traditionally, the effects of interventions have been assessed by measuring changes in the FEV 1

Treatment. Assessing the outcome of interventions Traditionally, the effects of interventions have been assessed by measuring changes in the FEV 1 58 COPD 59 The treatment of COPD includes drug therapy, surgery, exercise and counselling/psychological support. When managing COPD patients, it is particularly important to evaluate the social and family

More information

Wales Primary Care COPD Audit

Wales Primary Care COPD Audit Wales Primary Care COPD Audit 2014-15 Next steps for improvement National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme 2016 The audit programme partnership Working in strategic partnership:

More information

COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.

COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. 1 Definition of COPD: COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis. Airflow obstruction may be accompanied by airway hyper-responsiveness

More information

UNDERSTANDING COPD MEDIA BACKGROUNDER

UNDERSTANDING COPD MEDIA BACKGROUNDER UNDERSTANDING COPD MEDIA BACKGROUNDER What is COPD? Chronic Obstructive Pulmonary Disease (COPD) also called emphysema and/or chronic obstructive bronchitis* is a preventable lung disease caused by the

More information

INITIATING A COPD CLINIC: PROTOCOL & ASSESSMENT

INITIATING A COPD CLINIC: PROTOCOL & ASSESSMENT COPD Resource Pack Section 2A INITIATING A COPD CLINIC: PROTOCOL & ASSESSMENT In this section: 1. Initiating a COPD Clinic 2. Equipment for a COPD Clinic 3. Primary Care Chronic Obstructive Pulmonary Disease

More information

2017 GOLD Report. Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017

2017 GOLD Report. Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017 2017 GOLD Report Is it worth its weight in GOLD??? CSHP-NB Fall Education Day September 30, 2017 Lauren Munro; BSc(Pharm) Amanda Burns; BSc(Pharm) Pharmacy Residents The Moncton Hospital Objectives Explain

More information

SABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA

SABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA COPD GUIDELINES DIAGNOSIS >35 years of age Symptoms of cough, breathlessness, sputum, wheeze, Risk factor (SMOKING) Spirometry (post bronchodilator) FEV1/FVC = 0.7 ENCOURAGE PATIENTS TO BRING INHALERS

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Sickle cell acute episode: management of an acute painful sickle cell episode in hospital 1.1 Short title Sickle cell acute

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Centre for Clinical Practice SCOPE Clinical guideline title: Ulcerative colitis: the management of ulcerative colitis Quality standard title: Ulcerative

More information

Clinical guideline Published: 23 June 2010 nice.org.uk/guidance/cg101

Clinical guideline Published: 23 June 2010 nice.org.uk/guidance/cg101 Chronic obstructive pulmonary disease in over 16s: diagnosis and management Clinical guideline Published: 23 June 2010 nice.org.uk/guidance/cg101 NICE 2018. All rights reserved. Subject to Notice of rights

More information

Appendix D Clinical specialist statement template

Appendix D Clinical specialist statement template Appendix D Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of pseudomonas lung infection in cystic fibrosis Thank you for agreeing to give us a statement on your organisation

More information

PUBLIC HEALTH GUIDANCE FINAL SCOPE

PUBLIC HEALTH GUIDANCE FINAL SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE PUBLIC HEALTH GUIDANCE FINAL SCOPE 1 Guidance title How to stop smoking in pregnancy and following childbirth. 1.1 Short title Quitting smoking in

More information

Changing Healthcare Forever mycopd

Changing Healthcare Forever mycopd Changing Healthcare Forever mycopd Introducing mycopd, from my mhealth. mycopd is the most comprehensive, user friendly and intuitive COPD App available on any device. Built by COPD experts, and externally

More information

National COPD Audit Programme

National COPD Audit Programme National COPD Audit Programme Planning for every breath National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Primary care audit (Wales) 2015 17 Data analysis and methodology Section 2:

More information

Asthma: diagnosis and monitoring

Asthma: diagnosis and monitoring Asthma: diagnosis and monitoring NICE guideline: short version Draft for second consultation, July 01 This guideline covers assessing, diagnosing and monitoring suspected or confirmed asthma in adults,

More information

Copyright General Practice Airways Group. Reproduction Prohibited

Copyright General Practice Airways Group. Reproduction Prohibited Primary Care Respiratory Journal (2004) 13, 84 88 REVIEW The NICE COPD Guidelines 2004 what are the messages for primary care? David Bellamy*,1 James Fisher Medical Centre, 4 Tolpuddle Gardens, Muscliffe,

More information

Endobronchial valve insertion to reduce lung volume in emphysema

Endobronchial valve insertion to reduce lung volume in emphysema NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Interventional procedure consultation document Endobronchial valve insertion to reduce lung volume in emphysema Emphysema is a chronic lung disease that

More information

HEALTH NEEDS ASSESSMENT: DISEASES OF THE RESPIRATORY SYSTEM. A report assessing the respiratory health need of the population of Bolton

HEALTH NEEDS ASSESSMENT: DISEASES OF THE RESPIRATORY SYSTEM. A report assessing the respiratory health need of the population of Bolton EXECUTIVE SUMMARY HEALTH NEEDS ASSESSMENT: DISEASES OF THE RESPIRATORY SYSTEM January 2009 A report assessing the respiratory health need of the population of Bolton AUTHOR Mark Cook Public Health Intelligence

More information

THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable

THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause

More information

Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984]

Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984] Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984] 1 st Appraisal Committee meeting Background & Clinical Effectiveness John McMurray 11 th January 2016 For

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE QUALITY AND OUTCOMES FRAMEWORK (QOF) INDICATOR DEVELOPMENT PROGRAMME Briefing paper QOF indicator area: Primary prevention of CVD Potential output:

More information

Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease Page 1 of 5 Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) is an 'umbrella' term for people with chronic bronchitis, emphysema, or both. With COPD the airflow to the

More information

Guideline Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Guideline Chronic obstructive pulmonary disease in over 16s: diagnosis and management NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline Chronic obstructive pulmonary disease in over s: diagnosis and management Draft for consultation, July 0 This guideline covers diagnosing and

More information

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) TREATMENT GUIDELINES Document Description Document Type Service Application Version Guidelines All healthcare professionals(hcps) caring for patients with asthma

More information

How to treat COPD? What is the mechanism of dyspnea? Smoking cessation

How to treat COPD? What is the mechanism of dyspnea? Smoking cessation : The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease

More information

Guideline Chronic obstructive pulmonary disease in over 16s: diagnosis and management

Guideline Chronic obstructive pulmonary disease in over 16s: diagnosis and management NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline Chronic obstructive pulmonary disease in over s: diagnosis and management Draft for consultation, February 0 This guideline covers diagnosing

More information

HQO s Episode of Care for Chronic Obstructive Pulmonary Disease

HQO s Episode of Care for Chronic Obstructive Pulmonary Disease HQO s Episode of Care for Chronic Obstructive Pulmonary Disease Dr. Chaim Bell, MD PhD FRCPC Ontario Hospital Association Webcast October 23, 2013 Objectives 1. Describe the rationale and methodology for

More information

Information for Patients. Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years)

Information for Patients. Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years) Information for Patients Inhaler devices for routine treatment of chronic asthma in older children (aged 5-15 years) March 2002 Further information Further information on NICE and the full guidance on

More information

PCRS-UK briefing document Asthma guidelines. November 2017

PCRS-UK briefing document Asthma guidelines. November 2017 PCRS-UK briefing document Asthma guidelines November 2017 1 1. Background The Scottish Intercollegiate Guidelines Network (SIGN) and British Thoracic Society (BTS) have been collaborating on producing

More information

Disclosure Statement. Epidemiological Data

Disclosure Statement. Epidemiological Data EVALUATION OF THE MEDICATION UTILIZATION OF COPD PATIENTS AT THE MIAMI VA HEALTHCARE SYSTEM Simone Edgerton, PharmD. PGY 1 Pharmacy Resident Miami VA Healthcare System Miami, Florida Simone.edgerton2@va.gov

More information

Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines

Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines Chronic Obstructive Pulmonary Disease (COPD) Treatment Guidelines Where appropriate the following should be offered before commencing inhaled treatment: Offer treatment and support to stop smoking. Smoking

More information